Daiwa Securities Group’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-186
| Closed | -$20K | – | 1373 |
|
|
2023
Q1 | $20K | Buy |
186
+17
| +10% | +$1.83K | ﹤0.01% | 1070 |
|
|
2022
Q4 | $19K | Buy |
169
+23
| +16% | +$2.59K | ﹤0.01% | 1079 |
|
|
2022
Q3 | $9K | Hold |
146
| – | – | ﹤0.01% | 1129 |
|
|
2022
Q2 | $4K | Buy |
146
+32
| +28% | +$877 | ﹤0.01% | 1184 |
|
|
2022
Q1 | $4K | Hold |
114
| – | – | ﹤0.01% | 1199 |
|
|
2021
Q4 | $5K | Buy |
+114
| New | +$5K | ﹤0.01% | 1201 |
|